Clinical trials: Preeclampsia Severe
Preeclampsia
Low Doses of Aspirin in the Prevention of Preeclampsia
Preeclampsia (PE) is a morbid and potentially lethal complication of pregnancy and is more common in women with specific risk factors.
- Trial name
- ASAPP (NCT04070573)
- Testing
- acetylsalicylic acid
- Where
- 2 sites in United States
- Volunteers
- 400 people
- Sponsor
- Weill Medical College of Cornell University
Preeclampsia With Severe Features, Chronic Hypertension in Obstetric Context
Acute Control of Chronic Hypertension
The purpose of this study is to understand if administration of a personalized dose of the anti-hypertensive medication, labetalol, based on patient's history of preexisting hypertension, will be more effective at controlling…
- Trial name
- ACCTIVE (NCT03877692)
- Testing
- Experimental dosing of labetalol, Standard dosing of labetalol
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- Albany Medical College
Preeclampsia, Preeclampsia Severe
Risk Prediction Model of Preeclampsia
Preeclampsia is the main cause of increased maternal and perinatal mortality during pregnancy. Preeclampsia is mainly manifested as hypertension, urine protein, or damage symptoms of other target organs after 20 weeks of…
- Trial name
- NCT04794855
- Testing
- laboratory tests
- Where
- China
- Volunteers
- 2,000 people
- Sponsor
- Peking University Third Hospital
Pulmonary Edema
Predictors of Pulmonary Edema in Severe Preeclampsia
Pre-eclampsia is a multisystem major cardiovascular disease of pregnancy with hypertension its main clinical manifestation. Acute pulmonary edema, which signifies severe disease, is a leading cause of death in women with…
- Trial name
- NCT05095974
- Testing
- ultrasonography, echocardiography, thoracic electrical bioimpedence
- Volunteers
- 58 people, healthy volunteers welcome
- Sponsor
- Assiut University
Preeclampsia, Severe Preeclampsia
Identification of Genes of Interest for Severe Forms of Preeclampsia
Preeclampsia is a pregnancy complication characterized by high blood pressure associated with damage to various organs, especially the kidneys.
- Trial name
- PRE-OMIQUES (NCT07703826)
- Volunteers
- 100 people
- Sponsor
- University Hospital, Strasbourg, France